[1]
B. Zhan, L. Shi, B. Xu, and R. Chen, “Adverse Reactions and Management Principles of JAK Inhibitors in Rheumatoid Arthritis”, JCMP, vol. 8, no. 8, pp. 32–37, Aug. 2026.